Telix Pharmaceuticals rises after strong quarterly revenue

Telix Pharmaceuticals sees a stock rise following its quarterly revenue report.

Published 7sem1 sourceupdated 1sem

≈ 13sSpeed

The fact

The Australian medical imaging company exceeds analyst expectations.

Its oncology and urology products drive growth.

Click the link to read an article on the topic:

Explore this topic

Jul 21Telix Pharmaceuticals rises after strong quarterly revenuethis article

Auto-synthesis from 1 media source · identified on July 21, 2026